Detalhe da pesquisa
1.
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasis.
Cytokine
; 177: 156543, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373365
2.
Immunotherapy Combining Mimotopes Selected by Phage Display Plus Amphotericin B Is Effective for Treatment Against Visceral Leishmaniasis.
Parasite Immunol
; 46(5): e13037, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720446
3.
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Exp Parasitol
; 260: 108743, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513973
4.
Molecular characterization of cetacean poxviruses along the coast of mainland Portugal.
Dis Aquat Organ
; 158: 55-64, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661137
5.
Fluorescence intensity of composite resin for direct veneer removal using a fluorescence-aided identification technique.
J Esthet Restor Dent
; 36(7): 1050-1055, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500312
6.
Analysis of dentin wear and biological properties promoted by experimental inoffice desensitizing materials.
BMC Oral Health
; 24(1): 607, 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789946
7.
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Cytokine
; 164: 156143, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774730
8.
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Exp Parasitol
; 251: 108555, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247802
9.
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Parasitol Res
; 122(12): 2917-2931, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768367
10.
In vitro dentin permeability and tubule occlusion of experimental in-office desensitizing materials.
Clin Oral Investig
; 27(3): 1265-1276, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305964
11.
Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection.
Cytokine
; 153: 155865, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339043
12.
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis.
Microb Pathog
; 167: 105562, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513293
13.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Microb Pathog
; 162: 105341, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883228
14.
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis.
Parasite Immunol
; 44(8): e12921, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437797
15.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Exp Parasitol
; 233: 108205, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968460
16.
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
Microb Pathog
; 151: 104745, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485994
17.
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitology
; 148(13): 1706-1714, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35060464
18.
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Exp Parasitol
; 221: 108059, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338468
19.
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitol Res
; 120(12): 4037-4047, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664113
20.
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Parasitol Res
; 120(1): 321-335, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191446